Fennec Pharmaceuticals Inc
FENC - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$520.05M
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $520.05 Million |
|---|---|
| Enterprise Value | $481.98 Million |
| Earnings per Share | $-0.36 |
| Beta | 1.1 |
| Outstanding Shares | 34,545,000 |
Return
| Return on Equity | -8.69% |
|---|---|
| Return on Assets | -4.87% |
| Return on Invested Capital | -2.70% |
Valuation & Multiples
| P/E Ratio | -78.77 |
|---|---|
| PEG | 48.44 |
| Price to Sales | 10.54 |
| Price to Book Ratio | 10.54 |
| Enterprise Value to Revenue | 8.11 |
| Enterprise Value to EBIT | -281.8 |
| Enterprise Value to Net Income | -131 |
| Total Debt to Enterprise | 0.01 |
| Debt to Equity | 0.07 |
Revenue Sources
No data
Last Earnings Call
Report Date
August 13, 2026
EPS Estimate
$0.02
Consensus analyst estimateRevenue Estimate
$16.21 M
Consensus analyst estimateNext Earnings Call
Expected Date
November 5, 2026
EPS Estimate
$0.10
Consensus analyst estimateRevenue Estimate
$19.11 M
Consensus analyst estimateInstitutional Put/Call Ratio
Compares institutional put options with call options. At 0.00, the ratio is below 1, so institutions hold more calls than puts.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 1.53%▼ 45.91% |
|---|---|
| Total Invested | $5.64M▼ 96.79% |
| Investors Holding | 22▼ 87.00% |
About Fennec Pharmaceuticals Inc
35 employees
CEO: Rostislav Raykov
Fennec Pharmaceuticals Inc., a biopharmaceutical firm established in 1996, operates from its base in Research Triangle Park, North Carolina. The company's lead investigational compound, PEDMARK, is a sodium thiosulfate formulation curren...